Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR) expression, and human epidermal growth factor receptor-2 (HER-2) amplification, accounting for 10%-20% of all breast cancers [2–4]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.